1. Home
  2. ONCO vs DSS Comparison

ONCO vs DSS Comparison

Compare ONCO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • DSS
  • Stock Information
  • Founded
  • ONCO 2018
  • DSS 1984
  • Country
  • ONCO United States
  • DSS United States
  • Employees
  • ONCO N/A
  • DSS N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • ONCO Health Care
  • DSS Consumer Discretionary
  • Exchange
  • ONCO Nasdaq
  • DSS Nasdaq
  • Market Cap
  • ONCO 9.4M
  • DSS 7.3M
  • IPO Year
  • ONCO 2022
  • DSS N/A
  • Fundamental
  • Price
  • ONCO $0.54
  • DSS $0.91
  • Analyst Decision
  • ONCO
  • DSS
  • Analyst Count
  • ONCO 0
  • DSS 0
  • Target Price
  • ONCO N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • DSS 19.0K
  • Earning Date
  • ONCO 04-10-2025
  • DSS 03-26-2025
  • Dividend Yield
  • ONCO N/A
  • DSS N/A
  • EPS Growth
  • ONCO N/A
  • DSS N/A
  • EPS
  • ONCO N/A
  • DSS N/A
  • Revenue
  • ONCO $1,870,605.00
  • DSS $25,019,000.00
  • Revenue This Year
  • ONCO N/A
  • DSS N/A
  • Revenue Next Year
  • ONCO N/A
  • DSS N/A
  • P/E Ratio
  • ONCO N/A
  • DSS N/A
  • Revenue Growth
  • ONCO N/A
  • DSS N/A
  • 52 Week Low
  • ONCO $0.32
  • DSS $0.77
  • 52 Week High
  • ONCO $21.40
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.56
  • DSS 52.59
  • Support Level
  • ONCO $0.58
  • DSS $0.81
  • Resistance Level
  • ONCO $0.70
  • DSS $0.97
  • Average True Range (ATR)
  • ONCO 0.10
  • DSS 0.07
  • MACD
  • ONCO 0.01
  • DSS 0.01
  • Stochastic Oscillator
  • ONCO 5.94
  • DSS 63.64

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: